-
- What is FINACEA? FINACEA is unique. It is the first prescription topical gel approved
by the FDA for treating the redness, bumps, and pimples associated with mild to moderate rosacea.
- When you have mild to moderate rosacea, an effective topical treatment can help. To learn more, read about the benefits of FINACEA below and talk to your dermatologist about which treatment is best for you.
- By using FINACEA you can take
control of managing your mild to
moderate rosacea.
FINACEA starts working quickly
and keeps working:Patients in clinical studies who used FINACEA saw their symptoms improve in as early as 4 weeks. Continued use of FINACEA may help you maintain improvements over time.* The active ingredient in
FINACEA is naturally occurring:FINACEA contains AzA (azaleic acid), a safe, natural occurring ingredient. It comes in a water-based gel free of fragrance or alcohol and helps to limit allergic reaction and dryness. FINACEA may help improve your
skin’s appearance:
AzA, the active ingredient in FINACEA, has anti-inflammatory, antioxidant and germ killing properties. AzA helps reduce skin thickness, even skin tone and improve skins appearance. FINACEA is easy to use: You can incorporate FINACEA into any skin care routine because it's safe to use with any non-irritating skin care products and cosmetics. Simply apply it before you moisturize, and then follow with your normal makeup routine. -
- Before and After
- Check out the results of patients
with mild to moderate Rosacea - Go now
- * Results are for individual patients. Not all patients have the same results.
Other than FINACEA, Intendis, Inc. (part of the Bayer group) does not promote or endorse any products or recommendations made by third parties. All products and brand names listed are the property and responsibility of their respective trademark and copyright holders.
Intendis, Inc. reserves the right to terminate or modify this program at its sole discretion and without notice.
Finacea is indicated for topical treatment of inflammatory papules and pustules of mild to moderate rosacea. Although some reduction of erythema which was present in patients with papules and pustules of rosacea occurred in clinical studies, efficacy for treatment of erythema in rosacea in the absence of papules and pustules has not been evaluated.
Finacea is for dermatologic use only, and not for ophthalmic, oral, or intravaginal use. Finacea is contraindicated in individuals with a history of hypersensitivity to propylene glycol or any other component of the formulation. In clinical trials, sensations of burning/stinging/tingling occurred in 29% of patients, and itching in 11%, regardless of the relationship to therapy. Post-marketing safety - Skin: facial burning and irritation; Eyes: iridocyclitis on accidental exposure to the eye. There have been isolated reports of hypopigmentation after use of azelaic acid. Since azelaic acid has not been well studied in patients with a dark complexion, these patients should be monitored for early signs of hypopigmentation.
Images are for illustrative purposes only.